Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19

BACKGROUND: Since the beginning of COVID-19 pandemic, there has been a widespread use of remdesivir in adults and children. There is little known information about remdesivir's role in reducing 30-day readmissions after hospitalization with COVID-19. This study aimed to determine whether treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Finn, Arkadiy, Jindal, Atin, Andrea, Sarah B., Selvaraj, Vijairam, Dapaah-Afriyie, Kwame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830144/
https://www.ncbi.nlm.nih.gov/pubmed/35151637
http://dx.doi.org/10.1016/j.amjms.2022.01.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830144/
https://www.ncbi.nlm.nih.gov/pubmed/35151637
http://dx.doi.org/10.1016/j.amjms.2022.01.021

Ejemplares similares